NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NEO NeoGenomics

已收盘 05-02 16:00:00 EDT

14.72

+0.76

+5.44%

盘后14.72

+0.000.00%

17:32 EDT

最高14.75	最低13.69	成交量115.62万
今开14.03	昨收13.96	日振幅7.59%
总市值18.80亿	流通市值18.55亿	总股本1.28亿
成交额1,666万	换手率0.92%	流通股本1.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NEO","market":"US","secType":"STK","nameCN":"NeoGenomics","latestPrice":14.72,"timestamp":1714680000000,"preClose":13.96,"halted":0,"volume":1156180,"hourTrading":{"tag":"盘后","latestPrice":14.72,"preClose":14.72,"latestTime":"17:32 EDT","volume":200875,"amount":2956596.68,"timestamp":1714685579070},"delay":0,"floatShares":126052185,"shares":127711930,"eps":-0.669729,"marketStatus":"已收盘","marketStatusCode":5,"change":0.76,"latestTime":"05-02 16:00:00 EDT","open":14.03,"high":14.75,"low":13.69,"amount":16656636.662160002,"amplitude":0.075931,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.669729,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714723200000},"adr":0,"listingDate":1355115600000,"adjPreClose":13.96,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":13.98,"preClose":13.96,"latestTime":"09:29 EDT","volume":907,"amount":12520.768572,"timestamp":1714656569070},"postHourTrading":{"tag":"盘后","latestPrice":14.72,"preClose":14.72,"latestTime":"17:32 EDT","volume":200875,"amount":2956596.68,"timestamp":1714685579070},"volumeRatio":0.764385},"requestUrl":"/m/hq/s/NEO/wiki","defaultTab":"wiki","newsList":[{"id":"2432309952","title":"Needham：维持NeoGenomics(NEO.US)评级，由买入调整至买入评级, 目标价由24.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432309952","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432309952?lang=zh_cn&edition=full","pubTime":"2024-05-01 01:25","pubTimestamp":1714497914,"startTime":"0","endTime":"0","summary":"Needham：维持NeoGenomics(NEO.US)评级，由买入调整至买入评级, 目标价由24.00美元调整至19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050101251787c4bbd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050101251787c4bbd0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431322115","title":"BUZZ-Akili 因计划评估替代方案和裁员而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2431322115","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431322115?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:22","pubTimestamp":1714486946,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月30日 - ** 基于视频游戏的疗法制造商Akili公司  股价上涨80%至0.42美元** 公司称已开始评估潜在的替代方案 ** 称将裁员约46%，包括裁撤营销和医疗事务团队** AKLI 宣布修改与日本盐野义制药公司  的战略分销协议 ** 根据修订后的协议，Shionogi 取消了 500 万美元的长期债务义务** Akili将获得1050万美元的预付款，作为免除未来特许权使用费的对价** 包括盘中走势在内，股价下跌 22.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431324122","title":"Neogenomics 公司报告截至三月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2431324122","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431324122?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:13","pubTimestamp":1714486408,"startTime":"0","endTime":"0","summary":"   * Neogenomics Inc   报告了截至3月底的季度调整后每股亏损2美分，高于去年同期的每股-9美分。13 位分析师对该季度的平均预期是每股亏损 5 美分。华尔街预期为每股-11美分至-2美分。* Neogenomics 公司公布的本季度每股收益为亏损 21 美分。* 该公司当季亏损2706万美元。* Neogenomics Inc本季度股价下跌了3.2%，今年迄今为止下跌了5.9%。* 医疗设施与服务同行的平均一致建议也是 \"买入\"。华尔街对 Neogenomics Inc 的 12 个月目标价中位数为 20.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430277710","title":"Neogenomics Inc    预计每股亏损 5 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2430277710","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430277710?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:37","pubTimestamp":1714138660,"startTime":"0","endTime":"0","summary":"   * Neogenomics公司   将于4月30日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，12位分析师的平均预期是，这家总部位于佛罗里达州迈尔斯堡的公司的营收将从去年同期的1.3722亿美元增至1.4989亿美元，增幅为9.2%。* LSEG分析师对Neogenomics公司的平均预期是每股亏损5美分。* 华尔街对 Neogenomics Inc 的 12 个月目标价中位数为 20.00 美元，高于其上次收盘价 13.85 美元。4月26日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426972418","title":"NEO月线有可能走双顶反弹，反弹第一目标先看73","url":"https://stock-news.laohu8.com/highlight/detail?id=2426972418","media":"TradingView","top":-1,"share":"https://www.laohu8.com/m/news/2426972418?lang=zh_cn&edition=full","pubTime":"2024-04-09 05:23","pubTimestamp":1712611403,"startTime":"0","endTime":"0","summary":"NEO月线有可能走双顶反弹，反弹第一目标先看73\n\n\nNEOUSDT Perpetual Swap Contract OKX:NEOUSDT.P\n\n\nBernhardAnalytics\n\n\nNEO月线有可能走双顶反弹，反弹第一目标先看73","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://cn.tradingview.com/chart/NEOUSDT.P/2h8jGknB/","is_publish_highlight":false,"gpt_icon":0},{"id":"2414074158","title":"美国研究综述-Elf Beauty、Moderna、Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2414074158","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414074158?lang=zh_cn&edition=full","pubTime":"2024-02-26 15:57","pubTimestamp":1708934231,"startTime":"0","endTime":"0","summary":"    路透社2月26日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Elf Beauty、Moderna 和 Zscaler。要点             * 精灵美容公司  ：Piper Sandler将目标价从212美元上调至225美元             * Moderna   ：汇丰银行将目标价从持有下调至减持              * Zscaler Inc   ：摩根大通将目标价从212美元上调至240美元  以下是路透社周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413881445","title":"Neogenomics 公司报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2413881445","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413881445?lang=zh_cn&edition=full","pubTime":"2024-02-21 18:55","pubTimestamp":1708512944,"startTime":"0","endTime":"0","summary":"   * Neogenomics Inc   公布的截至12月底的季度调整后每股收益为3美分，高于去年同期的每股收益-6美分。13 位分析师对该季度的平均预期是每股亏损 2 美分。华尔街预期为每股-10美分至0美分。* 营收同比增长 12.1%，达到 1.555 亿美元；分析师预期为 1.5254 亿美元。* Neogenomics 公司公布的本季度每股收益为亏损 11 美分。* 该公司当季亏损1433万美元。* 本季度，Neogenomics Inc 的股价下跌了 9.1%。* 华尔街对 Neogenomics Inc 的 12 个月目标价中位数为 20.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neogenomics.com","stockEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0929},{"period":"3month","weight":-0.0568},{"period":"6month","weight":-0.0858},{"period":"1year","weight":-0.0127},{"period":"ytd","weight":-0.1372}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neogenomics, Inc.于1988年10月29日在内华达州注册成立。该公司专门从事癌症遗传学测试和信息服务，为医生提供世界上最全面的以肿瘤为中心的测试菜单之一，帮助他们诊断和治疗癌症。公司的药物服务部为制药客户提供临床试验和药物开发服务。1998年10月29日，母公司作为美国通信企业有限公司在内华达州注册成立，母公司在2001年12月14日更名为Neogenomics, Inc.。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.013981},{"month":2,"riseRate":0.583333,"avgChangeRate":0.054598},{"month":3,"riseRate":0.5,"avgChangeRate":-0.020301},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.02166},{"month":5,"riseRate":0.666667,"avgChangeRate":0.032647},{"month":6,"riseRate":0.636364,"avgChangeRate":0.045415},{"month":7,"riseRate":0.909091,"avgChangeRate":0.117804},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.025032},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.007257},{"month":10,"riseRate":0.636364,"avgChangeRate":0.066213},{"month":11,"riseRate":0.636364,"avgChangeRate":0.069094},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.030261}],"exchange":"NASDAQ","name":"NeoGenomics","nameEN":"NeoGenomics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeoGenomics(NEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeoGenomics,NEO,NeoGenomics股票,NeoGenomics股票老虎,NeoGenomics股票老虎国际,NeoGenomics行情,NeoGenomics股票行情,NeoGenomics股价,NeoGenomics股市,NeoGenomics股票价格,NeoGenomics股票交易,NeoGenomics股票购买,NeoGenomics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeoGenomics(NEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}